Shivakumar Hagalavadi Nanjappa

Unleashing the Potential of Spanlastics as Drug Delivery Carrier

Lakshmi Priya N S, Shivakumar Hagalavadi Nanjappa, Narahari K V, Arpitha Nandakumar, Sharath T P & Yashwanth S · Journal of Advances in Medical and Pharmaceutical Sciences · 2025

Spanlastics, a novel class of vesicular drug delivery systems, have garnered significant attention for their potential to overcome the limitations of traditional drug administration. Comprising non-ionic surfactants and edge activators, spanlastics exhibit unique characteristics...

Open access Research Article 10.9734/jamps/2025/v27i5776

Advances in Understanding and Treating Alzheimer’s Disease: From Pathogenesis to Novel Therapeutics and Biomarkers

Yashwanth S, Shivakumar Hagalavadi Nanjappa, Arpitha N, Thimappa Bhoomika Yadav & Lakshmi Priya N S · International Neuropsychiatric Disease Journal · 2025

Alzheimer's disease (AD), a progressive and unrelenting memory loss, gradually weakens cognitive and independent functioning. There is currently no cure despite decades of research, and existing medicines simply alleviate symptoms. A complex interaction between hereditary variabl...

Open access Research Article 10.9734/indj/2025/v22i3479

Oral Wafer Technology: Revolutionizing Drug Delivery for Enhanced Patient Compliance and Bioavailability of Specific Low Dose Drug Categories

Arpitha Nandakumar, Shivakumar Hagalavadi Nanjappa, Lakshmi Priya N S & Yashwanth S · Journal of Advances in Medical and Pharmaceutical Sciences · 2025

Oral wafer technology has emerged as a significant innovation in pharmaceutical drug delivery, offering enhanced therapeutic efficacy, patient compliance, and ease of administration compared to conventional dosage forms. These thin, rapidly dissolving films eliminate the need for...

Open access Research Article 10.9734/jamps/2025/v27i5775